Expression of tryptophan hydroxylase in gastric mucosa in symptomatic and asymptomatic Helicobacter pylori infection. 2019

Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, Lodz, Poland.

BACKGROUND Helicobacter pylori infection induces clinical symptoms in 15-20% of subjects, and the reason for this variation is still not clear. The aim of the present study is to evaluate the expression of tryptophan hydroxylase (TpH-1) in gastric mucosa of patients with symptomatic and asymptomatic H. pylori infection in relation to the intensity of bacterial colonization and severity of dyspeptic symptoms. METHODS Ninety subjects (aged 35-49 years) were enrolled in the study and separated into 3 groups of 30 subjects each. Group I - healthy volunteers without H. pylori infection, group II - subjects with asymptomatic H. pylori infection, group III - H. pylori-infected patients with dyspeptic symptoms, mainly fasting and nocturnal epigastric pain. To diagnose H. pylori infection the urea breath test (UBT-13C) and histological analysis were performed. The level of mRNA expression of tryptophan hydroxylase (TpH-1) was estimated in gastric mucosa with RT-PCR. RESULTS The expression of this enzyme in antral mucosa was 2.69 ±0.97 in group I, 2.28 ±0.69 in group II (p > 0.05) and 4.40 ±1.64 in group III (p < 0.001). The levels of expression of TpH-1 in gastric body mucosa were 2.16 ±0.70, 1.57 ±0.52 (p > 0.05) and 3.40 ±1.51 (p < 0.001), respectively. In group III a positive correlation was found between intensity of H. pylori colonization and TpH-1 expression as well as between TpH-1 expression and severity of dyspeptic symptoms. CONCLUSIONS Increased expression of TpH-1 in gastric mucosa plays a role in pathogenesis of chronic dyspepsia.

UI MeSH Term Description Entries

Related Publications

Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
February 1998, Journal of gastroenterology and hepatology,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
January 1996, The Journal of the American Board of Family Practice,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
December 1995, Scandinavian journal of gastroenterology,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
May 2003, World journal of gastroenterology,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
November 1998, Prostaglandins, leukotrienes, and essential fatty acids,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
June 2023, Helicobacter,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
July 1997, Helicobacter,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
November 2004, The American journal of gastroenterology,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
July 2023, The Kurume medical journal,
Cezary Chojnacki, and Tomasz Popławski, and Aleksandra Błońska, and Janusz Błasiak, and Marek Romanowski, and Jan Chojnacki
October 1998, Journal of gastroenterology,
Copied contents to your clipboard!